Reduction in severity of a herpes simplex virus type 1 murine infection by treatment with a ribozyme targeting the UL20 gene RNA

Journal of Virology

Volumn 82, Issue 15, 2008, Pages 7467-7474

  Liu, Jia ^a   Lewin, Alfred S ^a   Tuli, Sonal S ^a   Ghivizzani, Steven C ^a   Schultz, Gregory S ^a   Bloom, David C ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ADENOVIRUS VECTOR; GREEN FLUORESCENT PROTEIN; HAMMERHEAD RIBOZYME; VIRUS RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOOT; FOOT PAD; GANGLION; GENE TARGETING; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINAL CORD; SPINAL GANGLION; SURVIVAL; TISSUE CULTURE; VIRUS IMMUNITY; VIRUS LOAD; VIRUS REPLICATION; VIRUS STRAIN; VIRUS SURVIVAL; WILD TYPE;

ADENOVIRIDAE; ANIMALS; ANTIVIRAL AGENTS; DNA, VIRAL; FOOT; GANGLIA, SPINAL; GENE THERAPY; GENETIC VECTORS; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; KINETICS; MICE; RNA, CATALYTIC; SPINAL CORD; SURVIVAL ANALYSIS; TRANSDUCTION, GENETIC; VIRAL PROTEINS;

ADENOVIRIDAE; ANIMALIA; HUMAN HERPESVIRUS 1; MURINAE; MUS; SIMPLEXVIRUS;

EID: 47749104986     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02720-07     Document Type: Article

References (33)

1. L20 gene of herpes simplex virus 1 encodes a function necessary for viral egress. J. Virol. 65:6414-6424.
2. Coen, D. M., and P. A. Schaffer. 1980. Two distinct loci confer resistance to acycloguanosine in herpes simplex virus type 1. Proc. Natl. Acad. Sci. USA 77:2265-2269.
3. Davar, G., M. F. Kramer, D. Garber, A. L. Roca, J. K. Andersen, W. Bebrin, D. M. Coen, M. Kosz-Vnenchak, D. M. Knipe, and X. O. Breakefield. 1994. Comparative efficacy of expression of genes delivered to mouse sensory neurons with herpes virus vectors. J. Comp. Neurol. 339:3-11.
4. Davison, A. J., and J. E. Scott. 1986. The complete DNA sequence of varicella-zoster virus. J. Gen. Virol. 67:1759-1816.
5. Fedor, M. J., and J. R. Williamson. 2005. The catalytic diversity of RNAs. Nat. Rev. Mol. Cell Biol. 6:399-412.
6. Foster, T. P., J. M. Melancon, J. D. Baines, and K. G. Kousoulas. 2004. The herpes simplex virus type 1 UL20 protein modulates membrane fusion events during cytoplasmic virion morphogenesis and virus-induced cell fusion. J. Virol. 78:5347-5357.
7. Fritz, J. J., M. Gorbatyuk, A. S. Lewin, and W. W. Hauswirth. 2004. Design and validation of therapeutic hammerhead ribozymes for autosomal dominant diseases. Methods Mol. Biol. 252:221-236.
8. Fritz, J. J., D. A. White, A. S. Lewin, and W. W. Hauswirth. 2002. Designing and characterizing hammerhead ribozymes for use in AAV vector-mediated retinal gene therapies. Methods Enzymol. 346:358-377.
9. Fuchs, W., B. G. Klupp, H. Granzow, and T. C. Mettenleiter. 1997. The UL20 gene product of pseudorabies virus functions in virus egress. J. Virol. 71:5639-5646.
10. Gorbatyuk, M., V. Justilien, J. Liu, W. W. Hauswirth, and A. S. Lewin. 2007. Preservation of photoreceptor morphology and function in P23H rats using an allele independent ribozyme. Exp. Eye Res. 84:44-52.
11. Hardy, S., M. Kitamura, T. Harris-Stansil, Y. Dai, and M. L. Phipps. 1997. Construction of adenovirus vectors through Cre-lox recombination. J. Virol. 71:1842-1849.
12. Hatama, S., H. K. Jang, Y. Izumiya, J. S. Cai, Y. Tsushima, K. Kato, T. Miyazawa, C. Kai, E. Takahashi, and T. Mikami. 1999. Identification and DNA sequence analysis of the Marek's disease virus serotype 2 genes homologous to the herpes simplex virus type 1 UL20 and UL21. J. Vet. Med. Sci. 61:587-593.
13. Jacobson, J., M. Kramer, F. Rozenberg, A. Hu, and D. M. Coen. 1995. Synergistic effects on ganglionic herpes simplex virus infections by mutations or drugs that inhibit the viral polymerase and thymidine kinase. Virology 206:263-268.
14. Jacobson, J. G., S. H. Chen, W. J. Cook, M. F. Kramer, and D. M. Coen. 1998. Importance of the herpes simplex virus UL24 gene for productive ganglionic infection in mice. Virology 242:161-169.
15. Klupp, B. G., H. Kern, and T. C. Mettenleiter. 1992. The virulence-determining genomic BamHI fragment 4 of pseudorabies virus contains genes corresponding to the UL15 (partial), UL18, UL19, UL20, and UL21 genes of herpes simplex virus and a putative origin of replication. Virology 191:900-908.
16. Kubat, N. J., A. L. Amelio, N. V. Giordani, and D. C. Bloom. 2004. The herpes simplex virus type 1 latency-associated transcript (LAT) enhancer/rcr is hyperacetylated during latency independently of LAT transcription. J. Virol. 78:12508-12518.
17. Liesegang, T. J. 2001. Herpes simplex virus epidemiology and ocular importance. Cornea 20:1-13.
18. MacLean, C. A., S. Efstathiou, M. L. Elliott, F. E. Jamieson, and D. J. McGeoch. 1991. Investigation of herpes simplex virus type 1 genes encoding multiply inserted membrane proteins. J. Gen. Virol. 72:897-906.
19. Palliser, D., D. Chowdhury, Q. Y. Wang, S. J. Lee, R. T. Bronson, D. M. Knipe, and J. Lieberman. 2006. An siRNA-based microbicide protects mice from lethal herpes simplex virus 2 infection. Nature 439:89-94.
20. Palmer, G. D., E. Gouze, J. N. Gouze, O. B. Betz, C. H. Evans, and S. C. Ghivizzani. 2003. Gene transfer to articular chondrocytes with recombinant adenovirus. Methods Mol. Biol. 215:235-246.
21. Pepose, J. S., T. L. Keadle, and L. A. Morrison. 2006. Ocular herpes simplex: changing epidemiology, emerging disease patterns, and the potential of vaccine prevention and therapy. Am. J. Ophthalmol. 141:547-557.
22. Saldanha, R., G. Mohr, M. Belfort, and A. M. Lambowitz. 1993. Group I and group II introns. FASEB J. 7:15-24.
23. Shaw, L. C., P. O. Whalen, K. A. Drenser, W. Yan, W. W. Hauswirth, and A. S. Lewin. 2000. Ribozymes in treatment of inherited retinal disease. Methods Enzymol. 316:761-776.
24. Stevens, J. G., and M. L. Cook. 1973. Latent infections induced by herpes simplex viruses. Cancer Res. 33:1399-1401.
25. Thi, T. N., C. Deback, I. Malet, P. Bonnafous, Z. Ait-Arkoub, and H. Agut. 2006. Rapid determination of antiviral drug susceptibility of herpes simplex virus types 1 and 2 by real-time PCR. Antivir. Res. 69:152-157.
26. Tran, R. K., P. T. Lieu, S. Aguilar, E. K. Wagner, and D. C. Bloom. 2002. Altering the expression kinetics of VP5 results in altered virulence and pathogenesis of herpes simplex virus type 1 in mice. J. Virol. 76:2199-2205.
27. Trang, P., A. Kilani, J. Kim, and F. Liu. 2000. A ribozyme derived from the catalytic subunit of RNase P from Escherichia coli is highly effective in inhibiting replication of herpes simplex virus 1. J. Mol. Biol. 301:817-826.
28. Trang, P., J. Lee, A. F. Kilani, J. Kim, and F. Liu. 2001. Effective inhibition of herpes simplex virus 1 gene expression and growth by engineered RNase P ribozyme. Nucleic Acids Res. 29:5071-5078.
29. Vlcek, C., V. Benes, Z. Lu, G. F. Kutish, V. Paces, D. Rock, G. J. Letchworth, and M. Schwyzer. 1995. Nucleotide sequence analysis of a 30-kb region of the bovine herpesvirus 1 genome which exhibits a colinear gene arrangement with the UL21 to UL4 genes of herpes simplex virus. Virology 210:100-108.
30. Wagner, E. K., J. F. Guzowski, and J. Singh. 1995. Transcription of the herpes simplex virus genome during the productive and latent infections, p. 123-168. In W. E. Cohen and K. Moldave (ed.), Progress in nucleic acid research and molecular biology. Academic Press, San Diego, CA.
31. L20 membrane protein in cells infected with herpes simplex virus 1. J. Virol. 68:7406-7417.
32. Ward, P. L., B. Taddeo, N. S. Markovitz, and B. Roizman. 2000. Identification of a novel expressed open reading frame situated between genes U(L)20 and U(L)21 of the herpes simplex virus 1 genome. Virology 266:275-285.
33. Zuker, M. 2003. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 31:3406-3415.